EFFECTS OF TACROLIMUS ON HYPERLIPIDEMIA AFTER SUCCESSFUL RENAL TRANSPLANTATION

1998150 citationsJournal Article

Authors

Thomas R. McCune · Sentara Heart Hospital

Leroy R. Thacker · Association of Organ Procurement Organizations

Thomas G. Peters · Iowa Methodist Medical Center

Laura Mulloy · Augusta University

Michael S. Rohr · Wake Forest University

Patricia A. Adams · Wake Forest University

Jackson Joe Yium

Abstract

Conversion from cyclosporine to tacrolimus can be safely done after successful transplantation. Introduction of tacrolimus to a stable renal patient does not effect renal function or glycemic control. Tacrolimus can lower cholesterol, LDL, and apolipoprotein B. Conversion to tacrolimus from cyclosporine should be considered in the treatment of posttransplant hyperlipidemia.

Topics & Keywords

Renal Transplantation Outcomes and Treatments Pharmacological Effects and Toxicity Studies Neurological Complications and Syndromes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Transplantation

Volume 65, Issue 1, pp. 87-92

DOI: 10.1097/00007890-199801150-00017

Field-Weighted Citation Impact: 10.41